These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6748558)

  • 21. [Use of cannabinoids for chemotherapy-induced nausea and vomiting].
    Dräger DL
    Urologe A; 2018 Jan; 57(1):54-58. PubMed ID: 29260262
    [No Abstract]   [Full Text] [Related]  

  • 22. Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.
    Phillips RS; Gopaul S; Gibson F; Houghton E; Craig JV; Light K; Pizer B
    Cochrane Database Syst Rev; 2010 Sep; (9):CD007786. PubMed ID: 20824866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of chemotherapy-induced nausea and emesis.
    Maule WF; Perry MC
    Am Fam Physician; 1983 Jan; 27(1):226-34. PubMed ID: 6130699
    [No Abstract]   [Full Text] [Related]  

  • 24. [Research on antiemetics: an Italian model of success].
    Roila F
    Tumori; 1998; 84(1 Suppl):S3-11. PubMed ID: 9617377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are cannabinoids effective for the management of chemotherapy induced nausea and vomiting?
    Morales M; Corsi O; Peña J
    Medwave; 2017 Dec; 17(9):e7119. PubMed ID: 29286355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
    Herrstedt J
    Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer therapy, vomiting, and antiemetics.
    Stewart DJ
    Can J Physiol Pharmacol; 1990 Feb; 68(2):304-13. PubMed ID: 2178754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nausea and vomiting during treatment with cytostatics].
    Kaasa S; Mella O; Kvikstad A
    Tidsskr Nor Laegeforen; 1991 Mar; 111(8):941-4. PubMed ID: 2042209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic treatment of chemotherapy-induced nausea and vomiting.
    Fiore JJ; Gralla RJ
    Cancer Invest; 1984; 2(5):351-61. PubMed ID: 6093949
    [No Abstract]   [Full Text] [Related]  

  • 30. The control of chemotherapy-induced emesis.
    Seigel LJ; Longo DL
    Ann Intern Med; 1981 Sep; 95(3):352-9. PubMed ID: 7023313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
    Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
    Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Hansen O; Sörensen BT; Räisänen I; van Oosterom AT; de Bruijn KM
    Cancer; 1994 Jan; 73(2):445-54. PubMed ID: 8293412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.
    Perwitasari DA; Wessels JA; van der Straaten RJ; Baak-Pablo RF; Mustofa M; Hakimi M; Nortier JW; Gelderblom H; Guchelaar HJ
    Jpn J Clin Oncol; 2011 Oct; 41(10):1168-76. PubMed ID: 21840870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy-induced nausea and vomiting: which antiemetic for which therapy?
    Schwartzberg LS
    Oncology (Williston Park); 2007 Jul; 21(8):946-53; discussion 954, 959, 962 passim. PubMed ID: 17715696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metoclopramide, methylprednisolone and flunitrazepam in cytostatic-induced vomiting].
    Joss R; Rohrbach D; Pirovino M; Bischoff A; Kiser J; Brunner K
    Schweiz Med Wochenschr; 1987 Dec; 117(52):2113-7. PubMed ID: 3433092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nabilone and high-dose metoclopramide: anti-emetics for cancer chemotherapy.
    Drug Ther Bull; 1984 Feb; 22(3):9-11. PubMed ID: 6321126
    [No Abstract]   [Full Text] [Related]  

  • 37. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.
    Natale JJ
    Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoids for nausea and vomiting related to chemotherapy: Overview of systematic reviews.
    Schussel V; Kenzo L; Santos A; Bueno J; Yoshimura E; de Oliveira Cruz Latorraca C; Pachito DV; Riera R
    Phytother Res; 2018 Apr; 32(4):567-576. PubMed ID: 29168289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prophylaxis of chemotherapy-induced vomiting and nausea].
    Tóth J; Szántó J
    Magy Onkol; 2008 Dec; 52(4):391-4. PubMed ID: 19068468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The treatment of vomiting caused by the administration of cytostatic agents].
    de Wit R; Veenhof CH
    Ned Tijdschr Geneeskd; 1986 Aug; 130(33):1475-9. PubMed ID: 3531878
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.